| [1] |
Yasuoka K, Gotoh Y, Taniguchi I, et al. Genome analysis of Japanese yersinia pseudotuberculosis strains isolated from Kawasaki disease patients and other sources and their phylogenetic positions in the global Y.pseudotuberculosis population[J]. Microbiol Immunol, 2025, 69(3):182-190.doi:10.1111/1348-0421.13199.
|
| [2] |
Dixit J, Pilania RK, Nimesh R, et al. Public health impact of Kawasaki disease in India: Projections for 2030[J]. Indian Pediatr, 2025, 62(9):692-698. doi:10.1007/s13312-025-00121-6.
|
| [3] |
Kang CR, Lee JS, Choe YJ. Global incidence of Kawasaki disease: A systematic review[J]. Cardiol Young, 2025, 35(5):1028-1039.doi:10.1017/S104795112500191X.
|
| [4] |
Alkanhal A, Saunders J, Altammar F, et al. Unexpectedly high incidence of Kawasaki Disease in a Canadian Atlantic Province- an 11-year retrospective descriptive study[J]. Pediatr Rheumatol Online J, 2023, 21(1):30. doi:10.1186/s12969-023-00805-y.
pmid: 37013572
|
| [5] |
Mat Bah MN, Alias EY, Razak H, et al. Epidemiology, clinical characteristics, and immediate outcome of Kawasaki disease: A population-based study from a tropical country[J]. Eur J Pediatr, 2021, 180(8):2599-2606.doi:10.1007/s00431-021-04135-7.
pmid: 34086103
|
| [6] |
Makino N, Nakamura Y, Yashiro M, et al. Nationwide epidemiologic survey of Kawasaki disease in Japan, 2015-2016[J]. Pediatr Int, 2019, 61(4):397-403.doi:10.1111/ped.13809.
pmid: 30786118
|
| [7] |
Oshita Y, Okano I, Watanabe Y, et al. Clinical features of atlantoaxial rotatory fixation among children with Kawasaki disease[J]. J Pediatr Orthop B, 2025. doi:10.1097/BPB.0000000000001276.
|
| [8] |
Rowley AH, Shulman ST. The epidemiology and pathogenesis of Kawasaki disease[J]. Front Pediatr, 2018, 6:374.doi:10.3389/fped.2018.00374.
pmid: 30619784
|
| [9] |
Nowlen TT, Harahsheh AS, Raghuveer G, et al. Seasons of Kawasaki disease during the COVID-19 pandemic[J]. Cardiol Young, 2024, 34(11):2329-2332. doi:10.1017/S1047951124036047.
pmid: 39627984
|
| [10] |
Padilla LA, Idigo AJ, Maxwell K, et al. Seasonality and geographical distribution of Kawasaki disease among Black children in the Southeast United States[J]. Front Pediatr, 2023, 11:1203431.doi:10.3389/fped.2023.1203431.
|
| [11] |
Sano T, Makino N, Aoyama Y, et al. Temporal and geographical clustering of Kawasaki disease in Japan: 2007-2012[J]. Pediatr Int, 2016, 58(11):1140-1145.doi:10.1111/ped.12970.
pmid: 26940079
|
| [12] |
Hong L, Huang Y, Han J, et al. Pathogen-specific alterations in intestinal microbiota precede urinary tract infections in preterm infants: A longitudinal case-control study[J]. Gut Microbes, 2024, 16(1):2333413. doi:10.1080/19490976.2024.2333413.
|
| [13] |
Biswas L, Crain N, Spaeder MC, et al. iciHHV-6 in a patient with multisystem inflammatory syndrome in children[J]. Pediatrics, 2021, 148(3):e2021051297. doi:10.1542/peds.2021-051297.
|
| [14] |
Manlhiot C, Mueller B, OShea S, et al. Environmental epidemiology of Kawasaki disease: Linking disease etiology, pathogenesis and global distribution[J]. PLoS One, 2018, 13(2):e0191087.doi:10.1371/journal.pone.0191087.
|
| [15] |
Buda P, Chyb M, Smorczewska-Kiljan A, et al. Association Between rs12037447, rs146732504, rs151078858, rs55723436, and rs6094136 Polymorphisms and Kawasaki disease in the population of Polish children[J]. Front Pediatr, 2021, 9:624798.doi:10.3389/fped.2021.624798.
|
| [16] |
Zhang L, Lin K, Wang Y, et al. Protective effect of TNFRSF11A rs7239667 G>C gene polymorphism on coronary outcome of Kawasaki disease in Southern Chinese population[J]. Front Genet, 2021, 12:691282.doi:10.3389/fgene.2021.691282. eCollection 2021.
|
| [17] |
Galeotti C, Kaveri SV, Cimaz R, et al. Predisposing factors, pathogenesis and therapeutic intervention of Kawasaki disease[J]. Drug Discov Today, 2016, 21(11):1850-1857.doi:10.1016/j.drudis.2016.08.004.
pmid: 27506874
|
| [18] |
Assempoor R, Abroy AS, Azarboo A, et al. Different antithrombotic strategies to prevent cardiovascular complications in Kawasaki patients: A systematic review and meta-analysis[J]. BMC Pediatr, 2024, 24(1):738.doi:10.1186/s12887-024-05202-2.
pmid: 39548432
|
| [19] |
Visuddho V, Welliam Y, Maitri AF, et al. Exploring the therapeutic potential of vitamin D in Kawasaki disease and its interplay with the COVID-19[J]. Turk Arch Pediatr, 2024, 59(5):432-439.doi:10.5152/TurkArchPediatr.2024.24141.
|
| [20] |
Chang LY, Lu CY, Shao PL, et al. Viral infections associated with Kawasaki disease[J]. J Formos Med Assoc, 2014, 113(3):148-154.doi:10.1016/j.jfma.2013.12.008.
|
| [21] |
Jose J, Tierney ESS, Harahsheh AS, et al. COVID-19 positive versus negative complete Kawasaki disease: A study from the international Kawasaki Disease Registry[J]. Pediatr Cardiol, 2023, 44(6):1373-1381.doi:10.1007/s00246-023-03109-w.
pmid: 36786810
|
| [22] |
Hata A, Onouchi Y. Susceptibility genes for Kawasaki disease: Toward implementation of personalized medicine[J]. J Hum Genet, 2009, 54(2):67-73.doi:10.1038/jhg.2008.9.
pmid: 19158812
|
| [23] |
Barman P, Pilania RK, Cv G, et al. Treatment intensification in Kawasaki disease-current perspectives[J]. Expert Rev Clin Immunol, 2024, 20(10):1179-1191.doi:10.1080/1744666X.2024.2378900.
|
| [24] |
陕西省川崎病诊疗中心/陕西省人民医院儿童病院, 国家儿童医学中心/首都医科大学附属北京儿童医院, 上海交通大学医学院附属儿童医院, 等. 中国儿童川崎病诊疗循证指南(2023年)[J]. 中国当代儿科杂志, 2023, 25(12): 1198-1210.doi:10.7499/j.issn.1008-8830.2309038.
|
| [25] |
陕西省川崎病诊疗中心, 陕西省儿童内科疾病临床医学研究中心, 陕西省人民医院儿童病院, 等. 静脉输注免疫球蛋白在儿童川崎病中应用的专家共识[J]. 中国当代儿科杂志, 2021, 23(9): 867-876.doi:10.7499/j.issn.1008-8830.2107110.
|
| [26] |
陕西省川崎病诊疗中心/陕西省人民医院儿童病院, 首都医科大学附属北京儿童医院, 上海儿童医学中心, 等. 糖皮质激素在川崎病治疗中的儿科专家共识[J]. 中国当代儿科杂志, 2022, 24(3): 225-231.doi:10.7499/j.issn.1008-8830.2112033.
|
